Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Shah

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Thorax|May 21, 2009
Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysisK Adams, P L Shah, L Edmonds, et al.
The European Respiratory Journal|March 1, 1996
The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosisP L Shah, S F Scott, R A Knight, et al.
Respiratory Medicine|August 1, 1995
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosisP L Shah, S F Scott, D M Geddes, et al.
Thorax|December 23, 1999
Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesisP L Shah, D Hansell, P R Lawson, et al.
The European Respiratory Journal|January 7, 2000
Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasisP L Shah, S Mawdsley, K Nash, et al.
The European Respiratory Journal|May 4, 2010
An evaluation of a videobronchoscopy-based autofluorescence system in lung cancerE J Cetti, A G Nicholson, S Singh, et al.
Thorax|April 1, 1995
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase IP L Shah, S F Scott, H J Fuchs, et al.
Thorax|February 1, 1996
In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosisP L Shah, S F Scott, R A Knight, et al.
Respiration; International Review of Thoracic Diseases|April 5, 2001
A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year periodP L Shah, S Conway, S F Scott, et al.
Thorax|September 24, 1999
Increased carbon monoxide in exhaled air of patients with cystic fibrosisP Paredi, P L Shah, P Montuschi, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Thorax|May 21, 2009
Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysisK Adams, P L Shah, L Edmonds, et al.
The European Respiratory Journal|March 1, 1996
The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosisP L Shah, S F Scott, R A Knight, et al.
Respiratory Medicine|August 1, 1995
Two years experience with recombinant human DNase I in the treatment of pulmonary disease in cystic fibrosisP L Shah, S F Scott, D M Geddes, et al.
Thorax|December 23, 1999
Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesisP L Shah, D Hansell, P R Lawson, et al.
The European Respiratory Journal|January 7, 2000
Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasisP L Shah, S Mawdsley, K Nash, et al.
The European Respiratory Journal|May 4, 2010
An evaluation of a videobronchoscopy-based autofluorescence system in lung cancerE J Cetti, A G Nicholson, S Singh, et al.
Thorax|April 1, 1995
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase IP L Shah, S F Scott, H J Fuchs, et al.
Thorax|February 1, 1996
In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosisP L Shah, S F Scott, R A Knight, et al.
Respiration; International Review of Thoracic Diseases|April 5, 2001
A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year periodP L Shah, S Conway, S F Scott, et al.
Thorax|September 24, 1999
Increased carbon monoxide in exhaled air of patients with cystic fibrosisP Paredi, P L Shah, P Montuschi, et al.
Pageof 4